|
1
|
Quilty B, Tucker M, Campbell R and Dieppe
P: Physiotherapy, including quadriceps exercises and patellar
taping, for knee osteoarthritis with predominant patello-femoral
joint involvement: Randomized controlled trial. J Rheumatol.
30:1311–1317. 2003.PubMed/NCBI
|
|
2
|
Guccione AA, Felson DT, Anderson JJ,
Anthony JM, Zhang Y, Wilson PW, Kelly-Hayes M, Wolf PA, Kreger BE
and Kannel WB: The effects of specific medical conditions on the
functional limitations of elders in the Framingham Study. Am J
Public Health. 84:351–358. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Woolf AD and Pfleger B: Burden of major
musculoskeletal conditions. Bull World Health Organ. 81:646–656.
2003.
|
|
4
|
Parmet S, Lynm C and Glass RM: JAMA
patient page. Osteoarthritis of the knee. JAMA. 289:10682003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin CW, Taylor D, Bierma-Zeinstra SM and
Maher CG: Exercise for osteoarthritis of the knee. Phys Ther.
90:839–842. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fernandes JC, Martel-Pelletier J and
Pelletier JP: The role of cytokines in osteoarthritis
pathophysiology. Biorheology. 39:237–246. 2002.PubMed/NCBI
|
|
7
|
Zarling JM, Shoyab M, Marquardt H, Hanson
MB, Lioubin MN and Todaro GJ: Oncostatin M: A growth regulator
produced by differentiated histiocytic lymphoma cells. Proc Natl
Acad Sci USA. 83:9739–9743. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tanaka M and Miyajima A: Oncostatin M, a
multifunctional cytokine. Rev Physiol Biochem Pharmacol. 149:39–52.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brounais B, David E, Chipoy C, et al: Long
term oncostatin M treatment induces an osteocyte-like
differentiation on osteosarcoma and calvaria cells. Bone.
44:830–839. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jorcyk CL, Holzer RG and Ryan RE:
Oncostatin M induces cell detachment and enhances the metastatic
capacity of T-47D human breast carcinoma cells. Cytokine.
33:323–336. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brounais B, Chipoy C, Mori K, Charrier C,
Battaglia S, Pilet P, Richards CD, Heymann D, Rédini F and
Blanchard F: Oncostatin M induces bone loss and sensitizes rat
osteosarcoma to the antitumor effect of Midostaurin in vivo. Clin
Cancer Res. 14:5400–5409. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lisignoli G, Piacentini A, Toneguzzi S,
Grassi F, Cocchini B, Ferruzzi A, Gualtieri G and Facchini A:
Osteoblasts and stromal cells isolated from femora in rheumatoid
arthritis (RA) and osteoarthritis (OA) patients express IL-11,
leukaemia inhibitory factor and oncostatin M. Clin Exp Immunol.
119:346–353. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Hooge AS, van de Loo FA, Bennink MB,
Arntz OJ, Fiselier TJ, Franssen MJ, Joosten LA, Van Lent PL,
Richards CD and van den Berg WB: Growth plate damage, a feature of
juvenile idiopathic arthritis, can be induced by adenoviral gene
transfer of oncostatin M: A comparative study in gene-deficient
mice. Arthritis Rheum. 48:1750–1761. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Langdon C, Kerr C, Hassen M, Hara T,
Arsenault AL and Richards CD: Murine oncostatin M stimulates mouse
synovial fibroblasts in vitro and induces inflammation and
destruction in mouse joints in vivo. Am J Pathol. 157:1187–1196.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
de Hooge AS, van de Loo FA, Bennink MB, de
Jong DS, Arntz OJ, Lubberts E, Richards CD and vandDen Berg WB:
Adenoviral transfer of murine oncostatin M elicits periosteal bone
apposition in knee joints of mice, despite synovial inflammation
and up-regulated expression of interleukin-6 and receptor activator
of nuclear factor-kappa B ligand. Am J Pathol. 160:1733–1743. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Walker EC, McGregor NE, Poulton IJ,
Pompolo S, Allan EH, Quinn JM, Gillespie MT, Martin TJ and Sims NA:
Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation
required for normal bone remodeling. J Bone Miner Res.
23:2025–2032. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Walker EC, McGregor NE, Poulton IJ, et al:
Oncostatin M promotes bone formation independently of resorption
when signaling through leukemia inhibitory factor receptor in mice.
J Clin Invest. 120:582–592. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lisignoli G, Toneguzzi S, Pozzi C,
Piacentini A, Riccio M, Ferruzzi A, Gualtieri G and Facchini A:
Proinflammatory cytokines and chemokine production and expression
by human osteoblasts isolated from patients with rheumatoid
arthritis and osteoarthritis. J Rheumatol. 26:791–799.
1999.PubMed/NCBI
|
|
19
|
Richards GS and Degnan BM: The dawn of
developmental signaling in the metazoa. Cold Spring Harb Symp Quant
Biol. 74:81–90. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Calvi LM, Adams GB, Weibrecht KW, et al:
Osteoblastic cells regulate the haematopoietic stem cell niche.
Nature. 425:841–846. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoon K and Gaiano N: Notch signaling in
the mammalian central nervous system: Insights from mouse mutants.
Nat Neurosci. 8:709–715. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sassi N, Laadhar L, Driss M,
Kallel-Sellami M, Sellami S and Makni S: The role of the Notch
pathway in healthy and osteoarthritic articular cartilage: From
experimental models to ex vivo studies. Arthritis Res Ther.
13:2082011. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karlsson C, Brantsing C, Egell S and
Lindahl A: Notch1, Jagged1, and HES5 are abundantly expressed in
osteoarthritis. Cells Tissues Organs. 188:287–298. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sassi N, Laadhar L, Mahjoub M, Driss M,
Zitouni M, Benromdhane K, Makni S and Sellami S: Expression of
Notch family members in cultured murine articular chondrocytes.
Biotech Histochem. 84:313–320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jarriault S, Le Bail O, Hirsinger E,
Pourquié O, Logeat F, Strong CF, Brou C, Seidah NG and Israël A:
Delta-1 activation of notch-1 signaling results in HES-1
transactivation. Mol Cell Biol. 18:7423–7431. 1998.PubMed/NCBI
|
|
26
|
Sciaudone M, Gazzerro E, Priest L, Delany
AM and Canalis E: Notch 1 impairs osteoblastic cell
differentiation. Endocrinology. 144:5631–5639. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zamurovic N, Cappellen D, Rohner D and
Susa M: Coordinated activation of notch, Wnt, and transforming
growth factor-beta signaling pathways in bone morphogenic protein
2-induced osteogenesis. Notch target gene Hey1 inhibits
mineralization and Runx2 transcriptional activity. J Biol Chem.
279:37704–37715. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bai S, Kopan R, Zou W, Hilton MJ, Ong CT,
Long F, Ross FP and Teitelbaum SL: NOTCH1 regulates
osteoclastogenesis directly in osteoclast precursors and indirectly
via osteoblast lineage cells. J Biol Chem. 283:6509–6518. 2008.
View Article : Google Scholar
|
